Product Information
ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) is a generic product labeled by American Regent, Inc., priced at $2.5539 per ML under NDC 00517750425. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jul 28, 1995. Its Orange Book therapeutic-equivalence code is AN.
Strength
100 mg/mL
Manufacturer
American Regent, Inc.NDC
00517750425
Classification
Generic
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA072489FDA Approved
7/28/1995
TE Code
AN
On Market Since
10/1/1995
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5539 per ML |
|---|---|
| All-time high | $2.6433 (Aug 12, 2026) |
| All-time low | $1.8335 (Nov 20, 2024) |
| 52-week high | $2.6433 |
| 52-week low | $2.3268 |
| Median price | $2.2679 |
| Average price | $2.2463 |
| Largest weekly change | +11.7% (May 22, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acetylcysteine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Regent, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
acetylcysteine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antidote class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION), manufactured by American Regent, Inc., is $2.5539 per ML (NDC 00517750425), effective Sep 30, 2026.
How has the price of ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) has risen 37.2%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
Since Apr 17, 2024, the NADAC for ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) has ranged from a low of $1.8335 (Nov 20, 2024) to a high of $2.6433 (Aug 12, 2026), with a median of $2.2679 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
No other NADAC-published product currently shares the active ingredient and strength of ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 10% VIAL (NOT FOR INJECTION) (NDC 00517750425) is labeled by American Regent, Inc., and CMS classifies it as a generic product.